Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a global ...

Celltrion said on the 20th that it obtained additional approval from Health Canada for the auto-injector (AI) formulation of the autoimmune disease treatment biosimilar "Steqeyma" (ingredient name ...

Embecta, a company that develops diabetes management solutions, is moving into the auto-injection market with its latest planned acquisition. The Becton Dickinson & CO spinoff reported it would ...

For developers using AI, “vibe coding” right now comes down to babysitting every action or risking letting the model run unchecked. Anthropic says its latest update to Claude aims to eliminate that ...

Zepbound (tirzepatide) is a prescription drug used for weight loss and obstructive sleep apnea in certain adults. It works by reducing appetite and slowing digestion, which makes you consume fewer ...